StockData
Neuronetics, Inc. logo

Neuronetics, Inc. (STIM) stock

STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.39−0.04 (-2.80%)

Close on Nov 13, 2026Market cap $105.91MP/E –Yield –

Neuronetics gross margin

Gross margin is gross profit as a percentage of revenue.

Neuronetics's gross margin for the twelve months ending Sep 30, 2026 was 50.7%. For fiscal 2025 it was 48.5%, against 72.3% the year before. The highest annual figure on record is 80.7% in fiscal 2016.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202548.5%−23.8
FY2024Dec 31, 202472.3%−0.1
FY2023Dec 31, 202372.5%−3.8
FY2022Dec 31, 202276.3%−2.7
FY2021Dec 31, 202178.9%+2.4
FY2020Dec 31, 202076.5%+1.1
FY2019Dec 31, 201975.4%−1.0
FY2018Dec 31, 201876.4%+0.2
FY2017Dec 31, 201776.2%−4.5
FY2016Dec 31, 201680.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202652.2%+6.3
Q2 FY2026Jun 30, 202651.1%+4.5
Q1 FY2026Mar 31, 202646.9%−2.3
Q4 FY2025Dec 31, 202552.0%−14.3
Q3 FY2025Sep 30, 202545.9%−29.7
Q2 FY2025Jun 30, 202546.6%−27.4
Q1 FY2025Mar 31, 202549.2%−25.9
Q4 FY2024Dec 31, 202466.2%−11.4
Q3 FY2024Sep 30, 202475.6%+9.8
Q2 FY2024Jun 30, 202474.0%+1.5
Q1 FY2024Mar 31, 202475.1%+1.8
Q4 FY2023Dec 31, 202377.6%+1.8
Q3 FY2023Sep 30, 202365.8%−12.6
Q2 FY2023Jun 30, 202372.5%−2.7
Q1 FY2023Mar 31, 202373.3%−2.1
Q4 FY2022Dec 31, 202275.9%−0.6
Q3 FY2022Sep 30, 202278.4%+1.1
Q2 FY2022Jun 30, 202275.3%−5.4
Q1 FY2022Mar 31, 202275.4%−6.5
Q4 FY2021Dec 31, 202176.4%+0.6
Q3 FY2021Sep 30, 202177.2%−1.4
Q2 FY2021Jun 30, 202180.6%+4.5
Q1 FY2021Mar 31, 202181.9%+6.4
Q4 FY2020Dec 31, 202075.8%+0.2
Q3 FY2020Sep 30, 202078.7%+4.9
Q2 FY2020Jun 30, 202076.2%+1.3
Q1 FY2020Mar 31, 202075.5%−2.4
Q4 FY2019Dec 31, 201975.7%−0.6
Q3 FY2019Sep 30, 201973.8%−4.1
Q2 FY2019Jun 30, 201974.8%−0.7
Q1 FY2019Mar 31, 201977.9%+2.1
Q4 FY2018Dec 31, 201876.3%+0.7
Q3 FY2018Sep 30, 201877.9%+3.0
Q2 FY2018Jun 30, 201875.5%−0.2
Q1 FY2018Mar 31, 201875.8%−3.8
Q4 FY2017Dec 31, 201775.6%–
Q3 FY2017Sep 30, 201774.9%–
Q2 FY2017Jun 30, 201775.7%–
Q1 FY2017Mar 31, 201779.6%–

More Neuronetics figures

See a number that looks wrong?